Get started
METROPOLIS HEALTHCARE LIMITEDMETROPOLIS HEALTHCARE LIMITEDMETROPOLIS HEALTHCARE LIMITED

METROPOLIS HEALTHCARE LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

METROPOLIS chart


Full chart

METROPOLIS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪108.31 B‬ INR
Dividend yield (indicated)
0.19%
Price to earnings Ratio (TTM)
79.35
Basic EPS (TTM)
26.75 INR
Net income (FY)
‪1.28 B‬ INR
Revenue (FY)
‪12.08 B‬ INR
Shares float
‪25.91 M‬
Beta (1Y)
0.64

Employees


Employees (FY)
‪4.74 K‬
Change (1Y)
−25 −0.52%
Revenue / Employee (1Y)
‪30.55 K‬ INR
Net income / Employee (1Y)
‪3.23 K‬ INR

About METROPOLIS HEALTHCARE LTD


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Surendran Chemmenkotil
Website
metropolisindia.com
Headquarters
Mumbai
Founded
1981
ISIN
INE112L01020
FIGI
BBG00D6R1H51
Metropolis Healthcare Ltd. engages in the provision of medical laboratories. It operates through the India and Outside India geographical segments. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

METROPOLIS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of METROPOLIS is 2,115.20 INR — it has increased by 0.12% in the past 24 hours. Watch METROPOLIS HEALTHCARE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange METROPOLIS HEALTHCARE LIMITED stocks are traded under the ticker METROPOLIS.
METROPOLIS stock has fallen by −1.62% compared to the previous week, the month change is a −7.13% fall, over the last year METROPOLIS HEALTHCARE LIMITED has showed a 39.59% increase.
We've gathered analysts' opinions on METROPOLIS HEALTHCARE LIMITED future price: according to them, METROPOLIS price has a max estimate of 2,490.00 INR and a min estimate of 1,691.00 INR. Watch METROPOLIS chart and read a more detailed METROPOLIS HEALTHCARE LIMITED stock forecast: see what analysts think of METROPOLIS HEALTHCARE LIMITED and suggest that you do with its stocks.
METROPOLIS reached its all-time high on Dec 30, 2021 with the price of 3,579.00 INR, and its all-time low was 904.85 INR and was reached on May 14, 2019. View more price dynamics on METROPOLIS chart.
See other stocks reaching their highest and lowest prices.
METROPOLIS stock is 1.51% volatile and has beta coefficient of 0.64. Track METROPOLIS HEALTHCARE LIMITED stock price on the chart and check out the list of the most volatile stocks — is METROPOLIS HEALTHCARE LIMITED there?
Today METROPOLIS HEALTHCARE LIMITED has the market capitalization of ‪108.44 B‬, it has increased by 0.11% over the last week.
Yes, you can track METROPOLIS HEALTHCARE LIMITED financials in yearly and quarterly reports right on TradingView.
METROPOLIS HEALTHCARE LIMITED is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
METROPOLIS earnings for the last quarter are 9.00 INR per share, whereas the estimation was 9.13 INR resulting in a −1.41% surprise. The estimated earnings for the next quarter are 7.29 INR per share. See more details about METROPOLIS HEALTHCARE LIMITED earnings.
METROPOLIS HEALTHCARE LIMITED revenue for the last quarter amounts to ‪3.49 B‬ INR, despite the estimated figure of ‪3.49 B‬ INR. In the next quarter, revenue is expected to reach ‪3.26 B‬ INR.
METROPOLIS net income for the last quarter is ‪465.19 M‬ INR, while the quarter before that showed ‪379.47 M‬ INR of net income which accounts for 22.59% change. Track more METROPOLIS HEALTHCARE LIMITED financial stats to get the full picture.
As of Nov 10, 2024, the company has ‪4.74 K‬ employees. See our rating of the largest employees — is METROPOLIS HEALTHCARE LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. METROPOLIS HEALTHCARE LIMITED EBITDA is ‪3.14 B‬ INR, and current EBITDA margin is 24.84%. See more stats in METROPOLIS HEALTHCARE LIMITED financial statements.
Like other stocks, METROPOLIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade METROPOLIS HEALTHCARE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So METROPOLIS HEALTHCARE LIMITED technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating METROPOLIS HEALTHCARE LIMITED stock shows the buy signal. See more of METROPOLIS HEALTHCARE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.